Shapsis Why Some Patients Cannot Tolerate GLP-1 Weight Loss Medications Many patients start medications such as Semaglutide or Tirzepatide to help with weight loss
The timeline for experiencing semaglutide's effects varies depending on which outcomes you're monitoring
Although GLP-1s are a promising intervention for reducing multiple chronic conditions, it is important that future research focuses, too, on psychosocial health, especially in perimenopausal women who have greater utilization of GLP-1s and greater risk for adverse changes in physiological and psychosocial health relative to men and to younger and older women
LifeRx.md utilizes these treatments alongside professional medical guidance to ensure safety and effectiveness
Flash Glucose Monitoring Continues to Grow Despite the Presence of CGM Industry
Given the significant unmet need in obesity management and the weight loss outcomes observed in early trials, there is considerable clinical interest though formal NICE appraisal remains some years away